There is no doubt that vaping is better than smoking cannabis but even vaping can lead to respiratory problems. Moreover many medical cannabis users do not want the negative stigma commonly associated with “smoking weed.” Finally, in certain states, including New York, where medical cannabis is legal, dispensaries are not allowed to sell leaf or plant-like material to patients. This is causing medical cannabis companies to figure out creative ways in which to deliver cannabinoid-based products and remain compliant with individual state mandates and cannabis regulations.
Interestingly, many of these so-called innovative delivery methods for cannabis are routine delivery technologies that have already been tested, refined and approved by the US Food and Drug Administration (FDA). or example, Colorado-based Next Frontier Biosciences, founded by former biotechnology executives and research scientists, recently created a micro dosing-based, nasal mist delivery system intended for the pain management market segment. Likewise, similar companies with biotechnology and healthcare backgrounds are also developing time-release transdermal patches, sublingual sprays and suppository-based systems. These developments suggest that the medical cannabis industry is beginning to mature and is likely to become mainstream in the not-too-distant future.